These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 32891785)

  • 1. National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1.
    Gelfand JM; Armstrong AW; Bell S; Anesi GL; Blauvelt A; Calabrese C; Dommasch ED; Feldman SR; Gladman D; Kircik L; Lebwohl M; Lo Re V; Martin G; Merola JF; Scher JU; Schwartzman S; Treat JR; Van Voorhees AS; Ellebrecht CT; Fenner J; Ocon A; Syed MN; Weinstein EJ; Smith J; Gondo G; Heydon S; Koons S; Ritchlin CT
    J Am Acad Dermatol; 2020 Dec; 83(6):1704-1716. PubMed ID: 32891785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments.
    Gelfand JM; Armstrong AW; Bell S; Anesi GL; Blauvelt A; Calabrese C; Dommasch ED; Feldman SR; Gladman D; Kircik L; Lebwohl M; Lo Re V; Martin G; Merola JF; Scher JU; Schwartzman S; Treat JR; Van Voorhees AS; Ellebrecht CT; Fenner J; Ocon A; Syed MN; Weinstein EJ; Gondo G; Heydon S; Koons S; Ritchlin CT
    J Am Acad Dermatol; 2021 May; 84(5):1254-1268. PubMed ID: 33422626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 1.
    Mikuls TR; Johnson SR; Fraenkel L; Arasaratnam RJ; Baden LR; Bermas BL; Chatham W; Cohen S; Costenbader K; Gravallese EM; Kalil AC; Weinblatt ME; Winthrop K; Mudano AS; Turner A; Saag KG
    Arthritis Rheumatol; 2020 Aug; 72(8):1241-1251. PubMed ID: 32349183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Navigating immunosuppression in a pandemic: A guide for the dermatologist from the COVID Task Force of the Medical Dermatology Society and Society of Dermatology Hospitalists.
    Zahedi Niaki O; Anadkat MJ; Chen ST; Fox LP; Harp J; Micheletti RG; Nambudiri VE; Pasieka HB; Shinohara MM; Rosenbach M; Merola JF
    J Am Acad Dermatol; 2020 Oct; 83(4):1150-1159. PubMed ID: 32569797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 and biologics for psoriasis: A high-epidemic area experience-Bergamo, Lombardy, Italy.
    Carugno A; Gambini DM; Raponi F; Vezzoli P; Locatelli AGC; Di Mercurio M; Robustelli Test E; Sena P
    J Am Acad Dermatol; 2020 Jul; 83(1):292-294. PubMed ID: 32387660
    [No Abstract]   [Full Text] [Related]  

  • 6. The risk of respiratory tract infections and symptoms in psoriasis patients treated with interleukin 17 pathway-inhibiting biologics: A meta-estimate of pivotal trials relevant to decision making during the COVID-19 pandemic.
    Wan MT; Shin DB; Winthrop KL; Gelfand JM
    J Am Acad Dermatol; 2020 Aug; 83(2):677-679. PubMed ID: 32416207
    [No Abstract]   [Full Text] [Related]  

  • 7. American College of Rheumatology Guidance for the Management of Pediatric Rheumatic Disease During the COVID-19 Pandemic: Version 2.
    Wahezi DM; Lo MS; Rubinstein TB; Ringold S; Ardoin SP; Downes KJ; Jones KB; Laxer RM; Pellet Madan R; Mudano AS; Turner AS; Karp DR; Mehta JJ
    Arthritis Rheumatol; 2021 Aug; 73(8):e46-e59. PubMed ID: 34114365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID-19 Pandemic: Version 3.
    Mikuls TR; Johnson SR; Fraenkel L; Arasaratnam RJ; Baden LR; Bermas BL; Chatham W; Cohen S; Costenbader K; Gravallese EM; Kalil AC; Weinblatt ME; Winthrop K; Mudano AS; Turner A; Saag KG
    Arthritis Rheumatol; 2021 Feb; 73(2):e1-e12. PubMed ID: 33277981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic inflammatory skin diseases and biologics: what to expect after COVID-19 pandemic?
    Megna M; Fabbrocini G; Marasca C
    Int J Dermatol; 2020 Sep; 59(9):1144-1145. PubMed ID: 32710548
    [No Abstract]   [Full Text] [Related]  

  • 10. Telemedicine for inpatient dermatology consultations in response to the COVID-19 pandemic.
    Trinidad J; Kroshinsky D; Kaffenberger BH; Rojek NW
    J Am Acad Dermatol; 2020 Jul; 83(1):e69-e71. PubMed ID: 32339708
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment discontinuation and rate of disease transmission in psoriasis patients receiving biologic therapy during the COVID-19 pandemic: A Canadian multicenter retrospective study.
    Georgakopoulos JR; Mufti A; Vender R; Yeung J
    J Am Acad Dermatol; 2020 Oct; 83(4):1212-1214. PubMed ID: 32679279
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessing the risk of adalimumab use for hidradenitis suppurativa during the COVID-19 pandemic.
    Kearns DG; Chat VS; Uppal S; Wu JJ
    J Am Acad Dermatol; 2020 Dec; 83(6):e433-e434. PubMed ID: 32735966
    [No Abstract]   [Full Text] [Related]  

  • 13. Global reporting of cases of COVID-19 in psoriasis and atopic dermatitis: an opportunity to inform care during a pandemic.
    Mahil SK; Yiu ZZN; Mason KJ; Dand N; Coker B; Wall D; Fletcher G; Bosma A; Capon F; Iversen L; Langan SM; Di Meglio P; Musters AH; Prieto-Merino D; Tsakok T; Warren RB; Flohr C; Spuls PI; Griffiths CEM; Barker J; Irvine AD; Smith CH;
    Br J Dermatol; 2020 Aug; 183(2):404-406. PubMed ID: 32348554
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical considerations for managing dermatology patients on systemic immunosuppressive or biologic therapy, or both, during the COVID-19 pandemic.
    Sanchez DP; Kirsner RS; Lev-Tov H
    J Am Acad Dermatol; 2020 Jul; 83(1):288-292. PubMed ID: 32380214
    [No Abstract]   [Full Text] [Related]  

  • 15. International surgical guidance for COVID-19: Validation using an international Delphi process - Cross-sectional study.
    Aj B; C B; T A; Harper E R; Rl H; Rj E;
    Int J Surg; 2020 Jul; 79():309-316. PubMed ID: 32531308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complicated coronavirus disease 2019 (COVID-19) in a psoriatic patient treated with ixekizumab.
    Facheris P; Valenti M; Pavia G; Gargiulo L; Narcisi A; Costanzo A; Borroni RG
    Int J Dermatol; 2020 Aug; 59(8):e267-e268. PubMed ID: 32557532
    [No Abstract]   [Full Text] [Related]  

  • 17. Asynchronous teledermatology in medical education: Lessons from the COVID-19 pandemic.
    Su MY; Lilly E; Yu J; Das S
    J Am Acad Dermatol; 2020 Sep; 83(3):e267-e268. PubMed ID: 32553635
    [No Abstract]   [Full Text] [Related]  

  • 18. Assessing the risk of dupilumab use for atopic dermatitis during the COVID-19 pandemic.
    Kearns DG; Uppal S; Chat VS; Wu JJ
    J Am Acad Dermatol; 2020 Sep; 83(3):e251-e252. PubMed ID: 32534081
    [No Abstract]   [Full Text] [Related]  

  • 19. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2.
    Henderson LA; Canna SW; Friedman KG; Gorelik M; Lapidus SK; Bassiri H; Behrens EM; Ferris A; Kernan KF; Schulert GS; Seo P; Son MBF; Tremoulet AH; Yeung RSM; Mudano AS; Turner AS; Karp DR; Mehta JJ
    Arthritis Rheumatol; 2021 Apr; 73(4):e13-e29. PubMed ID: 33277976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guiding principles for prioritization of limited in-person dermatology appointments during the COVID-19 pandemic.
    Stoff BK; Blalock TW; Swerlick RA; MacKelfresh JB; Lawley LP; Chen SC
    J Am Acad Dermatol; 2020 Oct; 83(4):1228-1230. PubMed ID: 32682028
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.